Screener
NeoGenomics NEO Accounts Receivable
Accounts Receivable at other companies
Other financials
Where this comes from
Reported directly by NeoGenomics in its filing.
Tagged under the XBRL concept us-gaap:AccountsReceivableNetCurrent.
The source filing: NeoGenomics’s 10-Q, filed July 28, 2026.
- Filed
- Jul 28, 2026, 4:09 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001077183-26-000059
| Line item | (unaudited)June 30, 2026 | December 31, 2025 |
|---|---|---|
| ASSETS | ||
| Current assets | ||
| Cash and cash equivalents | $145,539 | $159,618 |
| Accounts receivable, net | 175,405 | 159,242 |
| Inventories | 27,137 | 28,566 |
| Prepaid assets | 23,590 | 21,443 |
| Other current assets | 9,807 | 7,417 |
| Total current assets | 381,478 | 376,286 |
Item 1. Financial Statements (unaudited)
FAQ
- What is NeoGenomics's accounts receivable?
- NeoGenomics (NEO) reported accounts receivable of $175.41M in Q2 2026.
- How has NeoGenomics's accounts receivable changed year-over-year?
- NeoGenomics's accounts receivable increased by 14.6% year-over-year, from $153.13M to $175.41M.
- What is the long-term trend for NeoGenomics's accounts receivable?
- Over 5 years (2020 to 2025), NeoGenomics's accounts receivable has grown at a 8.3% compound annual growth rate (CAGR), from $106.84M to $159.24M.
- What does accounts receivable mean?
- Amounts owed by customers for goods delivered or services performed, net of allowances for doubtful accounts. A key working capital component.
Ask your AI about NeoGenomics's accounts receivable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude